Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments. The researchers designed and used an AI-based strategy to identify compounds that block the clumping, or aggregation, of alpha-synuclein, the protein that characterises Parkinson’s.